Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Royal Bank of Canada (NY:RY)

117.70 +2.50 (+2.17%)
Streaming Delayed Price Updated: 2:52 PM EDT, Apr 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Royal Bank of Canada

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Danaher Makes A Bullish Move On 'Solid' Report, Promising Tariffs Plan
The company's commentary on tariffs was a "pleasant surprise," according to one analyst. 
Via Investor's Business Daily
Topics Economy Government World Trade
Exposures Political Supply Chain Tariff
Are Hospital Stocks At Risk Amid Medicaid Funding Fears? RBC Downplays Worries While Retail Eyes Q1 Results
The Wall Street Journal highlighted UHS, THC and HCA as key beneficiaries of Medicaid supplemental payment programs that cost the federal government hundreds of billions. 
Via Stocktwits
Topics Government
Exposures Political
Chipotle Mexican Grill Q1 Preview: Retail Gets Bullish As Traders Eye Tariff Commentary, Expansion Plans
The burrito chain has maintained that it will not increase the prices of its menu items and will offset higher input costs through automation and other initiatives. 
Via Stocktwits
Topics World Trade
Exposures Tariff
Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost
The new FDA commissioner had a few key ideas for the agency in an interview with Megyn Kelly. 
Via Investor's Business Daily
Topics Government
Exposures Political Product Safety
American Express' Solid Revenue, Spending Trends Drive Analyst Optimism
RBC analyst maintains Outperform rating on American Express (AXP) with $310 price target. AXP reports strong Q1 2025 results, reaffirms revenue and EPS outlook. 
Via Benzinga
Looking Into RBC Bearings's Recent Short Interest
Via Benzinga
3 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade
Consider buying these top-notch AI-powered stocks in the current market dip. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With It
The companies are facing off with their heart drugs in a growing disease area. 
Via Investor's Business Daily
We Asked Retail Traders Where Tesla's Next 20% Move Is — Most Say ‘Higher’ Despite Growing Short Interest
Optimists think a bad earnings report is already priced in and hope CEO Elon Musk will soon announce his exit from Trump’s administration. 
Via Stocktwits
Topics Bankruptcy Electric Vehicles Government
Exposures Electric Vehicles Financial Legal
Canadian Banks Ranking 2025 – Which Bank To Hold?
Whether you already hold one of these financial giants or are considering adding a bank to your portfolio, this will help you understand key strengths, weaknesses, and long-term investment potential. 
Via Talk Markets
Topics Stocks / Equities
Energy Transfer: Tariff-Resistant Midstream Resilience
Energy Transfer showcases potential for investors through its record financial achievements, distribution yield, and strategic diversification efforts. 
Via MarketBeat
Topics World Trade
Exposures Tariff
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.
From vaccines to fluoride and beef tallow, here's where Robert F. Kennedy Jr. is making changes to health care. 
Via Investor's Business Daily
Topics Government
Exposures Political Product Safety
Wall Street Analysts Are Slashing Their Stock Market Forecasts. Here's What You Should Do, According to History.
Via The Motley Fool
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Economy Political
CorMedix Stock Rises After Preliminary Q1 Results Exceeds Expectations: Retail’s Elated
The company expects quarterly adjusted earnings before interest, taxes, depreciation, and amortisation (EBITDA) to exceed $22.5 million once final numbers are reported, exceeding expectations of $14.78... 
Via Stocktwits
Exposures Product Safety
Pacira Biosciences Stock Rises On Patent Litigation Settlement: Retail Sentiment Soars
RBC Capital opined that Pacira's settlement of litigation for generic Exparel, which provides some closure to over a year's worth of overhang and uncertainty for shares, is a win for the company and... 
Via Stocktwits
Topics Intellectual Property
Exposures Intellectual Property
5 Consumer Stocks That Hit 52-Week Lows Last Week On Trump's Tariff Shockwaves
Retailers and consumer-facing companies are reeling more prominently as they fear the potential hike to consumer prices of their products will directly hurt sales. 
Via Stocktwits
Topics Economy Government Lawsuit
Exposures Financial Interest Rates Legal
Woodside Energy In Spotlight After 40% Stake Sale In Louisiana LNG, Retail’s Bullish
Stonepeak will provide $5.7 billion for the development of Louisiana LNG on an accelerated basis. 
Via Stocktwits
Topics World Trade
Exposures Tariff
Badger Meter Gets an Upgrade—2 Stocks That Could Follow
RBC analysts just boosted Badger Meter stock, but the broader theme behind this view might lead investors to other similar opportunities. 
Via MarketBeat
Topics Economy Government World Trade
Exposures Economy Political Tariff
Chewy Stock Is About as Cheap as It's Ever Been. 1 Thing to Know Before You Buy.
Via The Motley Fool
Topics Economy
Exposures Interest Rates
BlackBerry's QNX, Secure Comms Growth Weighed Down By Tariff Uncertainties, Government Election Shifts: Analyst
RBC Capital Markets analyst maintains BlackBerry with Sector Perform rating, lowers price target to $3.75 due to lower revenue and EBITDA guidance for fiscal 2026. 
Via Benzinga
Sarepta Plunges After EMA Puts Gene Therapy Studies On Hold Following Teen's Death
The holds are temporary while the teenager's death is under investigation. 
Via Investor's Business Daily
Topics Death
Exposures Death
Will the Stock Market Crash or Soar in 2025? Wall Street Analysts Are Changing Their Forecasts.
Via The Motley Fool
Topics Economy Government
Exposures Economy Political
Enphase Energy Stock Declines After Jefferies Cuts Price Target Amid Demand Concerns: Retail Remains Bearish
The brokerage highlighted that the outlook for residential demand for Enphase’s products remains challenged due to worsening sentiment with respect to the Inflation Reduction Act. 
Via Stocktwits
Topics Artificial Intelligence Economy Government
Exposures Artificial Intelligence Interest Rates Political
Tesla (NQ:TSLA) Stock Drops on Q1 Vehicle Delivery Miss
April 2, 2025 – Tesla, Inc. (NQ:TSLA) shares fell sharply in morning trading today after the electric vehicle giant reported first-quarter vehicle deliveries that significantly undershot Wall Street... 
Via MarketMinute
Topics Earnings Electric Vehicles
Exposures Electric Vehicles Financial
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies
The sector's recent slide follows Peter Marks' resignation last week as the Food and Drug Administration's top vaccine regulator following a clash with Kennedy. 
Via Stocktwits
Topics ETFs Government
Exposures COVID-19 Political Product Safety
Bloom Energy Rises After Power Supply Agreement With Conagra, Fuels Retail Optimism
The company’s fuel cells would supply about 70% to 75% of the electricity needs at two Conagra facilities. 
Via Stocktwits
Topics Artificial Intelligence Emissions Government
Exposures Artificial Intelligence Political Tariff
Enphase Energy Stock Gains On Acquiring Over 2,500 SunPower Customers With Its Monitoring Services: Retail Remains Bearish
Earlier, analysts at RBC Capital noted that while Enphase has a strong opportunity to return to growth eventually, in the near term, the company continues to cede market share amid softening demand. 
Via Stocktwits
Topics Bankruptcy
Exposures Financial Legal
Biotech Stocks Take Another Beating As 'Chaos' Reigns At FDA With Reports Of Mass Firings
Reports of mass firings include another high-profile official as Robert F. Kennedy Jr. and Marty Makary take up their new roles. 
Via Investor's Business Daily
Topics Workforce
Exposures COVID-19 Layoff Product Safety
Why Sarepta Therapeutics (SRPT) Stock Is Nosediving
Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT) fell 10.8% in the afternoon session after RBC analyst Brian Abrahams downgraded the stock from a Buy to a Hold rating and slashed the price... 
Via StockStory
Moderna, Vaxcyte, Novavax Hammered After Key FDA Official Peter Marks Resigns
Peter Marks heads up the department in charge of reviewing vaccines, genetic medicines and cell therapies. 
Via Investor's Business Daily
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.